sb 216763 has been researched along with Cirrhosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Hou, J; Shen, L; Wang, L; Zhang, J; Zhu, Y | 1 |
| Chen, XL; Dai, HY; Ding, XJ; Guo, NF; Peng, WS; Zhang, Y; Zhang, YD; Zhou, QL | 1 |
| Akhmetshina, A; Bergmann, C; Beyer, C; Dees, C; Distler, JH; Distler, O; Palumbo, K; Schett, G; Zerr, P; Zwerina, J | 1 |
3 other study(ies) available for sb 216763 and Cirrhosis
| Article | Year |
|---|---|
Effects of chronic alcohol exposure on ischemia-reperfusion-induced acute kidney injury in mice: the role of β-arrestin 2 and glycogen synthase kinase 3.
Topics: Acute Kidney Injury; Alcoholism; Analysis of Variance; Animals; beta-Arrestin 2; Blood Alcohol Content; Blood Urea Nitrogen; Creatinine; Disease Models, Animal; Fibrosis; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Kidney; Male; Maleimides; Mice; Mice, Inbred C57BL; Mice, Knockout; Myofibroblasts; Reperfusion Injury | 2017 |
SB-216763, a GSK-3β inhibitor, protects against aldosterone-induced cardiac, and renal injury by activating autophagy.
Topics: Aldosterone; Animals; Autophagy; Cytokines; Fibrosis; Glycogen Synthase Kinase 3 beta; Heart Diseases; Indoles; Inflammation; Kidney Diseases; Male; Maleimides; Rats; Rats, Wistar | 2018 |
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway.
Topics: Animals; Bleomycin; Cells, Cultured; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Fibroblasts; Fibrosis; Gene Knockdown Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Male; Maleimides; Mice; Mice, Inbred DBA; RNA, Small Interfering; Scleroderma, Systemic; Skin; Wnt Signaling Pathway | 2011 |